Lifestyle Guidance Methods in NAFLD
INDIANA
The Investigation of Different Guidance Methods to Facilitate Lifestyle Changes in Patients With NAFLD
1 other identifier
interventional
300
1 country
1
Brief Summary
To determine the efficiency of lifestyle modification (due to a dietitian or digital application) compared to standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2022
CompletedFirst Submitted
Initial submission to the registry
November 7, 2022
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedJuly 9, 2025
July 1, 2025
2.4 years
November 7, 2022
July 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
A change in liver fat
As measured by the controlled attenuation parameter in the intervention arms as compared to standard of care
1 year
Study Arms (3)
Standard of care
OTHERLifestyle coach
EXPERIMENTALApp
EXPERIMENTALInterventions
Patients will receive standardized lifestyle advice by their specialist
Eligibility Criteria
You may qualify if:
- NAFLD based in FibroScan measurements
You may not qualify if:
- excessive alcohol use
- other causes of liver disease
- secondary causes of liver steatosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ziekenhuis Oost-Limburg
Genk, Limburg, 3600, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geert Robaeys, MD. PhD
Hasselt University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 7, 2022
First Posted
March 31, 2023
Study Start
October 24, 2022
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
July 9, 2025
Record last verified: 2025-07